{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:19:58Z","timestamp":1758845998646,"version":"3.44.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.pop.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T10:27:54Z","timestamp":1619087274000},"page":"299-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre-exposure Prophylaxis in LGBT Communities"],"prefix":"10.1016","volume":"48","author":[{"given":"Asa","family":"Radix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona","family":"Vail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2021.02.004_bib1","unstructured":"UNAIDS Joint United Nations Programme on HIV\/AIDS. UNAIDS DATA 2019. Geneva (Switzerland). 2019."},{"issue":"4","key":"10.1016\/j.pop.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1071\/SH16034","article-title":"Prevalence and correlates of condom use among sexually active men who have sex with men in the United States: findings from the National Survey of Family Growth, 2002, 2006-10 and 2011-13","volume":"14","author":"Abara","year":"2017","journal-title":"Sex Health"},{"issue":"Suppl 5","key":"10.1016\/j.pop.2021.02.004_bib3","first-page":"266","article-title":"Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States","volume":"7","author":"Reece","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"18","key":"10.1016\/j.pop.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.pop.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"Garc\u00eda-Lerma","year":"2008","journal-title":"PLoS Med"},{"issue":"27","key":"10.1016\/j.pop.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pop.2021.02.004_bib7","first-page":"65","article-title":"Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"10.1016\/j.pop.2021.02.004_bib8","first-page":"463","article-title":"Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"10.1016\/j.pop.2021.02.004_bib9","first-page":"586","article-title":"Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.pop.2021.02.004_bib10","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2019.6390","article-title":"Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement","volume":"321","year":"2019","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.pop.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society\u2013USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pop.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.AOG.0000446855.78026.21","article-title":"ACOG Committee Opinion no 595: Committee on Gynecologic Practice: Preexposure prophylaxis for the prevention of human immunodeficiency virus","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"10246","key":"10.1016\/j.pop.2021.02.004_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"issue":"9883","key":"10.1016\/j.pop.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.pop.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study","volume":"4","author":"Molina","year":"2017","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.pop.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0000000000000597","article-title":"Long-acting injectable cabotegravir for the prevention of HIV infection","volume":"15","author":"Clement","year":"2020","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.pop.2021.02.004_bib17","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Updated); vol. 31. 2020."},{"key":"10.1016\/j.pop.2021.02.004_bib18","first-page":"e1","article-title":"Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017","author":"Becasen","year":"2018","journal-title":"Am J Public Health"},{"issue":"7\u20138","key":"10.1016\/j.pop.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/17441692.2015.1134613","article-title":"A\u00a0global research synthesis of HIV and STI biobehavioural risks in female-to-male transgender adults","volume":"11","author":"Reisner","year":"2016","journal-title":"Glob Public Health"},{"issue":"8","key":"10.1016\/j.pop.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/apc.2010.0059","article-title":"A\u00a0mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men","volume":"24","author":"Reisner","year":"2010","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"10.1016\/j.pop.2021.02.004_bib21","first-page":"347","article-title":"Lesbian and bisexual women in small cities--at risk for HIV? HIV Prevention Community Collaborative","volume":"111","author":"Norman","year":"1996","journal-title":"Public Health Rep"},{"issue":"41","key":"10.1016\/j.pop.2021.02.004_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity - United States, 2014-2016","volume":"67","author":"Huang","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.pop.2021.02.004_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annepidem.2018.06.009","article-title":"Trends in the use of oral emtricitabine\/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017","volume":"28","author":"Sullivan","year":"2018","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.pop.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/QAI.0000000000002403","article-title":"HIV Testing and PrEP use in a national probability sample of sexually active transgender people in the United States","volume":"84","author":"Sevelius","year":"2020","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.pop.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000002116","article-title":"High rates of PrEP eligibility but low rates of PrEP access among a national sample of transmasculine individuals","volume":"82","author":"Golub","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.pop.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"e25391","DOI":"10.1002\/jia2.25391","article-title":"High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States","volume":"22","author":"Reisner","year":"2019","journal-title":"J\u00a0Int AIDS Soc"},{"issue":"6","key":"10.1016\/j.pop.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"e0128971","DOI":"10.1371\/journal.pone.0128971","article-title":"Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in san francisco, 2013","volume":"10","author":"Wilson","year":"2015","journal-title":"PLoS One"},{"issue":"7\u20138","key":"10.1016\/j.pop.2021.02.004_bib28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/17441692.2016.1154085","article-title":"'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women","volume":"11","author":"Sevelius","year":"2016","journal-title":"Glob Public Health"},{"issue":"2","key":"10.1016\/j.pop.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.2105\/AJPH.2014.302322","article-title":"The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men","volume":"105","author":"Eaton","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.pop.2021.02.004_bib30","article-title":"Intersecting barriers to PrEP awareness and uptake in black men who have sex with men in Atlanta, GA: a syndemic perspective","author":"Sullivan","year":"2020","journal-title":"Int J Behav Med"},{"issue":"11","key":"10.1016\/j.pop.2021.02.004_bib31","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s10461-018-2102-9","article-title":"Barriers and facilitators to oral PrEP use among transgender women in New York City","volume":"22","author":"Rael","year":"2018","journal-title":"AIDS Behav"},{"issue":"6","key":"10.1016\/j.pop.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/lgbt.2017.0098","article-title":"Perceived barriers to HIV prevention services for transgender youth","volume":"5","author":"Fisher","year":"2018","journal-title":"LGBT Health"},{"issue":"10","key":"10.1016\/j.pop.2021.02.004_bib33","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1080\/00918369.2017.1321379","article-title":"A\u00a0qualitative study examining young adults\u2019 experiences of disclosure and nondisclosure of LGBTQ identity to health care providers","volume":"64","author":"Rossman","year":"2017","journal-title":"J\u00a0Homosexuality"},{"issue":"9","key":"10.1016\/j.pop.2021.02.004_bib34","doi-asserted-by":"crossref","first-page":"e0238375","DOI":"10.1371\/journal.pone.0238375","article-title":"Healthcare practitioner experiences and willingness to prescribe pre-exposure prophylaxis in the US","volume":"15","author":"Leech","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pop.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","article-title":"A\u00a0cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians","volume":"32","author":"Blackstock","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"issue":"12","key":"10.1016\/j.pop.2021.02.004_bib36","first-page":"1924","article-title":"Sexual history-taking among primary care physicians","volume":"98","author":"Wimberly","year":"2006","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"7","key":"10.1016\/j.pop.2021.02.004_bib37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2105\/AJPH.94.7.1186","article-title":"Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4\u00a0US cities","volume":"94","author":"Metsch","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/j.pop.2021.02.004_bib38","unstructured":"Centers for Disease Control and Prevention: US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017\u00a0Update: a clinical practice guideline."},{"issue":"4","key":"10.1016\/j.pop.2021.02.004_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP15950.OR","article-title":"Metabolic effects of hormone therapy in transgender patients","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.pop.2021.02.004_bib40","article-title":"Approach to interpreting common laboratory pathology tests in transgender individuals","author":"Cheung","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.pop.2021.02.004_bib41","article-title":"HPTN 078: high prevalence of HCV antibodies among urban U.S. men who have sex with men (MSM) independent of HIV status","author":"Irvin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.pop.2021.02.004_bib42","first-page":"1","article-title":"CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.pop.2021.02.004_bib43","first-page":"296","article-title":"Acceptability of self-collecting oropharyngeal swabs for sexually transmissible infection testing among men and women","volume":"16","author":"Dangerfield Ii","year":"2019","journal-title":"Sex Health"},{"issue":"4","key":"10.1016\/j.pop.2021.02.004_bib44","doi-asserted-by":"crossref","first-page":"e0124310","DOI":"10.1371\/journal.pone.0124310","article-title":"Obtaining self-samples to diagnose curable sexually transmitted infections: a systematic review of patients\u2019 experiences","volume":"10","author":"Paudyal","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pop.2021.02.004_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1071\/SH13029","article-title":"Comparative effectiveness and acceptability of home-based and clinic-based sampling methods for sexually transmissible infections screening in females aged 14-50 years: a systematic review and meta-analysis","volume":"10","author":"Odesanmi","year":"2013","journal-title":"Sex Health"},{"issue":"4","key":"10.1016\/j.pop.2021.02.004_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007435-199407000-00005","article-title":"Gonococcal infection of the neovagina in a male-to-female transsexual","volume":"21","author":"Bodsworth","year":"1994","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.pop.2021.02.004_bib47","doi-asserted-by":"crossref","first-page":"ofz470","DOI":"10.1093\/ofid\/ofz470","article-title":"Chlamydia trachomatis infection of the neovagina in transgender women","volume":"6","author":"Radix","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.pop.2021.02.004_bib48","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/cid\/ciw022","article-title":"Symptoms, side effects and adherence in the iPrEx open-label extension","volume":"62","author":"Glidden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.pop.2021.02.004_bib49","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/infdis\/jir184","article-title":"Increasing clarity on bone loss associated with antiretroviral initiation","volume":"203","author":"Yin","year":"2011","journal-title":"J\u00a0Infect Dis"},{"year":"2020","series-title":"New York state Department of health AIDS Institute clinical guidelines. PrEP to prevent HIV and Promote sexual health","author":"Vail","key":"10.1016\/j.pop.2021.02.004_bib50"},{"issue":"9","key":"10.1016\/j.pop.2021.02.004_bib51","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.pop.2021.02.004_bib52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1071\/SH18120","article-title":"A\u00a0systematic evaluation of mobile apps to improve the uptake of and adherence to HIV pre-exposure prophylaxis","volume":"15","author":"Sharpe","year":"2018","journal-title":"Sex Health"},{"issue":"1","key":"10.1016\/j.pop.2021.02.004_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1185\/03007995.2014.978939","article-title":"Packaging interventions to increase medication adherence: systematic review and meta-analysis","volume":"31","author":"Conn","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.pop.2021.02.004_bib54","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/S2352-3018(17)30068-1","article-title":"Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial","volume":"4","author":"Markowitz","year":"2017","journal-title":"Lancet HIV"},{"issue":"11","key":"10.1016\/j.pop.2021.02.004_bib55","doi-asserted-by":"crossref","first-page":"e1002690","DOI":"10.1371\/journal.pmed.1002690","article-title":"Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial","volume":"15","author":"Landovitz","year":"2018","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.pop.2021.02.004_bib56","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(20)30497-7","article-title":"Cabotegravir, a new option for PrEP","volume":"20","author":"Kirby","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.pop.2021.02.004_bib57","doi-asserted-by":"crossref","first-page":"e788","DOI":"10.1016\/S2352-3018(19)30238-3","article-title":"Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline","volume":"6","author":"Coelho","year":"2019","journal-title":"Lancet HIV"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454321000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454321000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:45:21Z","timestamp":1758815121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454321000063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0095454321000063"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2021.02.004","relation":{},"ISSN":["0095-4543"],"issn-type":[{"type":"print","value":"0095-4543"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure Prophylaxis in LGBT Communities","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}